List of Funding Rounds (20/44) List of Funding Rounds in Europe Tech in September 2021 Europe Tech: List of Funding Rounds Note: Seed Stage (Seed, Angel), Early Stage (Series A, Series B), Late Stage (Series C+), PE 24 EARLY STAGE $47.3M - Series B Skello (2016, Paris, $54.2M) Team and task management software Partech Partners, XAnge, Aglae Ventures EARLY STAGE $50.0M - Series A Schuttflix (2018, Gutersloh, $58.7M) Provider of an online marketplace for procuring building materials Draper Esprit, HV Capital, STRABAG, Speedinvest EARLY STAGE $50.0M - Series A Koyo (2018, London, $61.4M) Online marketplace for personal loans Force Over Mass Capital, Forward Partners, Seedcamp, Frontline Ventures, Matt Robinson EARLY STAGE $50.0M - Series A Formo (2019, Berlin, $54.5M) Platform offering dairy alternative products EQT Ventures, Elevat3 Capital, Lowercarbon Capital, Good Seed Ventures, Happiness Capital, and 6 more EARLY STAGE $59.0M - Series B Hydrogenious LOHC Technologies (2013, Erlangen, $84.3M) Provider of large scale hydrogen storage solutions JERA, AP Ventures, Vopak, Pavilion Capital Partners, Temasek, and 2 more EARLY STAGE $60.0M - Series B Lifebit (2017, London, $70.9M) AI and SaaS-based genomics analysis software for drug development Tiger Global Management, Pentech Ventures, Beacon Capital Partners, Eurazeo EARLY STAGE $60.4M - Series A Anjarium Biosciences (2016, Wadenswil, $60.4M) Developer of next generation non-viral gene therapies Abingworth, Gimv, Pfizer, Citadel, Omega Funds EARLY STAGE $80.0M - Series B CoachHub (2018, Berlin, $131.7M) Digital coaching solutions provider for corporates Draper Esprit, HV Capital, RTP Ventures, Partech Partners, Signals VC, and 1 more EARLY STAGE $80.0M - Series B Amolyt Pharma (2015, Ecully, $154.8M) Developer of peptides for the treatment of rare endocrine and metabolic disorders Sectoral Asset Management, Andera Partners, Kurma Partners, Novo Holdings, Orbimed, and 8 more